Singapore, May 2 -- In a recent announcement, US-based medtech startup neuro42 has secured undisclosed investments from investor, Karna D Shinde. This is Karna's third round of investment in the company. neuro42, a game changer technology in the field of neurosurgery recently received US FDA clearance for its innovative diagnostic MRI product. The 510(k) clearance, received in February 2024, marks a significant milestone for neuro42 and sets the stage for the commercialisation of its cutting-edge diagnostic MRI machine later this year.

neuro42's portable MRI is designed to specialise in imaging the brain and head, with a key focus on MR-guided interventions. One of the primary drivers of innovation at neuro42 is its ability to amplify th...